Zobrazeno 1 - 10
of 18
pro vyhledávání: '"K. Linda Tang"'
Autor:
Keith C. Lantz, Tracy A. McGowan, Marsha Wolfson, Robert A. Bailey, Wayne Langholff, K. Linda Tang
Publikováno v:
Dialysis & Transplantation. 38:407-411
OBJECTIVES Hemoglobin (Hgb) variability when treating anemia in pre-dialysis chronic kidney disease (CKD) patients with erythropoietin stimulating agents (ESAs) may be an important safety consideration, as significant Hgb fluctuations over time appea
Autor:
Marc Leiserowitz, Daniel L. Lorber, Stephen L. Aronoff, William M. McClellan, K. Linda Tang, Sally Hood, Brian Wasserman, W. Kline Bolton, Thomas F. Tse
Publikováno v:
Current Medical Research and Opinion. 20:1501-1510
Anemia is a complication of chronic kidney disease and may contribute to adverse clinical outcomes. Early identification and treatment of anemia may improve cardiovascular morbidity and mortality. No large-scale population data are available specific
Autor:
Mitchell L. Shiffman, Mark S. Sulkowski, Zobair M. Younossi, Paul J. Pockros, Eugene R. Schiff, Peter J. Bowers, Betty L. Goon, Douglas T. Dieterich, Nezam H. Afdhal, K. Linda Tang, Teresa L. Wright
Publikováno v:
Gastroenterology. 126:1302-1311
Background & Aims: Combination therapy with interferon α (IFN-α) and ribavirin (RBV) or pegylated IFN-α (PEG-IFN-α)/RBV for chronic hepatitis C virus (HCV) infection often causes anemia, prompting RBV dose reduction/discontinuation. This study as
Autor:
André F. De Champlain, K. Linda Tang
Publikováno v:
Educational and Psychological Measurement. 57:174-178
The assumption of unidimensionality is central to most item response theory (IRT) models. Procedures based on McDonald's nonlinear factor analytic model and accompanying principle of weak local independence have proven to be useful with respect to id
Autor:
K. Linda Tang, James Algina
Publikováno v:
Multivariate Behavioral Research. 28:391-405
Type I error rates (τ) of four multivariate tests - Pillai-Bartlett trace, Johansen's test, James' first order test and James' second order test - were compared for heterogeneous covariance matrices. A total of 360 simulated experiments were conduct
Publikováno v:
Journal of Educational Statistics. 16:125-139
Type I error rates for Yao’s, James’ first order, James’ second order, and Johansen’s tests of equality of mean vectors for two independent samples were estimated for various conditions defined by the degree of heteroscedasticity and nonnorma
Autor:
Bruce, Spinowitz, Michael, Germain, Robert, Benz, Marsha, Wolfson, Tracy, McGowan, K Linda, Tang, Marc, Kamin, R, Weiss
Background and objectives: Although epoetin alfa is commonly initiated weekly (QW) in anemic chronic kidney disease (CKD) patients, recent evidence indicates that it can be initiated every 2 wk (Q2W) and used in maintenance therapy every 4 wk (Q4W).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b95e9997137ec9265e51acaeb8e01e83
https://europepmc.org/articles/PMC2440274/
https://europepmc.org/articles/PMC2440274/
Autor:
Mark Klausner, C. Venkata Ram, Sarbani Bhaduri, K. Linda Tang, Michael J. Germain, Mario Curzi
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 20(10)
Background The effectiveness of extended dosing of epoetin alfa beyond once-weekly (QW) has not been well explored in patients being treated for anaemia of chronic kidney disease (CKD). The current study was undertaken to assess the effectiveness of
Autor:
Teresa L. Wright, Eugene R. Schiff, Gerhard Leitz, Mitchell L. Shiffman, Zobair M. Younossi, Betty L. Goon, Nezam H. Afdhal, Paul J. Pockros, Mark S. Sulkowski, K. Linda Tang, Samir H. Mody, Douglas T. Dieterich, Peter J. Bowers
Publikováno v:
Hepatology (Baltimore, Md.). 40(6)
Anemia and decreased health-related quality of life (HRQL) are common in patients receiving combination therapy of interferon alfa (IFN) and ribavirin (RBV) for chronic hepatitis C virus (HCV) infection. In a randomized, prospective study evaluating
Autor:
Nezam H, Afdhal, Douglas T, Dieterich, Paul J, Pockros, Eugene R, Schiff, Mitchell L, Shiffman, Mark S, Sulkowski, Teresa, Wright, Zobair, Younossi, Betty L, Goon, K Linda, Tang, Peter J, Bowers
Publikováno v:
Gastroenterology. 126(5)
Combination therapy with interferon alpha (IFN-alpha) and ribavirin (RBV) or pegylated IFN-alpha (PEG-IFN-alpha)/RBV for chronic hepatitis C virus (HCV) infection often causes anemia, prompting RBV dose reduction/discontinuation. This study assessed